Evidence map›Paper›PMID 35386336›Full record

ArticleBioactive materials2022

Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification.

Jieqiong Cao, Yibo Zhang, Peiguang Zhang, Zilei Zhang, Bihui Zhang, Yanxian Feng, Zhixin Li, Yiqi Yang, Qilin Meng, Liu He and 8 more

Open access · goldAbstract read
In one paragraph

Article in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Nanomaterials-Based Immunotherapy for Atherosclerosis.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Jieqiong CaoInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Yibo ZhangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Peiguang ZhangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Zilei ZhangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Bihui ZhangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Yanxian FengSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, 529020, China.
Zhixin LiInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Yiqi YangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Qilin MengInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Liu HeInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Yulin CaiInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Zhenyu WangInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Jie LiInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Xue ChenInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Hongwei LiuDepartment of Plastic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
An HongInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Wenjie ZhengDepartment of Chemistry, Jinan University, Guangzhou, China.
Xiaojia ChenInstitute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial biotechnology drug & Engineering Technology Research Center, National Engineering Research Center of Genetic Medicine, Guangzhou, China.
Jinan University · CNWuyi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium (Se) is an essential trace element involved in nearly all human physiological processes but suffers from a narrow margin between benefit and toxicity. The nanoform of selenium has been proven shown to be more bioavailable and less toxic, yet significant challenges remain regarding the efficient and feasible synthesis of biologically active nanoselenium. In addition, although nanoselenium has shown a variety of biological activities, more interesting nanoselenium features are expected. In this work, hydrosoluble nanoselenium termed Nano-Se in the zero oxidation state was synthesized between gray Se and PEG. A zebrafish screen was carried out in zebrafish larvae cocultured with Nano-Se. Excitingly, Nano-Se promoted the action of the FGFR, Wnt, and VEGF signaling pathways, which play crucial roles in tissue regeneration. As expected, Nano-Se not only achieved the regeneration of zebrafish tail fins and mouse skin but also promoted the repair of skin in diabetic mice while maintaining a profitable safe profile. In brief, the Nano-Se reported here provided an efficient and feasible method for bioactive nanoselenium synthesis and not only expanded the application of nanoselenium to regenerative medicine but also likely reinvigorated efforts for discovering more peculiarunique biofunctions of nanoselenium in a great variety of human diseases.

Indexed as

NanoseleniumPEG modificationTissue regenerationZebrafish

Identifiers

PMID35386336
PMCPMC8940942
OpenAlexW4206747629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.